dvc1-0101
Gene therapyexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2014 (NCT02276937)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Basic fibroblast growth factorSupplementation
FGF2 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dvc1-0101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02276937 | Phase 2 | Oct 1, 2014 | CPC Clinical Research, Government of Japan, Iberica Co. Ltd., Kyushu University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CPC Clinical Research | For profit | 1 | 0 | 1 | 2014 |
| Government of Japan | Government | 1 | 0 | 1 | 2014 |
| Iberica Co. Ltd. | For profit | 1 | 0 | 1 | 2014 |
| Kyushu University | Academic/Hospital | 1 | 1 | 1 | 2014 |
4 organizations
Page 1 / 1